Search research articles
Contact Us
Filters
Showing results (1-10 of 283) with videos related to
Page
of 29
Sort By:
Biomarker Insights
|
July 7, 2009
Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
Giannis Mountzios, Meletios-Athanasios Dimopoulos, Christos Papadimitriou
Critical Reviews in Oncology/Hematology
|
March 11, 2025
PARP inhibitors during conception and pregnancy in breast cancer
Flora Zagouri, Meletios-Athanasios Dimopoulos, Angeliki Andrikopoulou
Hemasphere
|
September 5, 2020
Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
Despina Fotiou, Meletios Athanasios Dimopoulos, Efstathios Kastritis
Clinical Lymphoma, Myeloma & Leukemia
|
May 30, 2026
Monoclonal Gammopathy of Clinical Significance: A Multisystem Disorder Requiring a Multidisciplinary Approach
Meletios Athanasios Dimopoulos, Foteini Theodorakakou, Efstathios Kastritis
Cancers
|
December 23, 2022
Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma
Despina Fotiou, Meletios Athanasios Dimopoulos, Efstathios Kastritis
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios-Athanasios Dimopoulos, Paul Richardson, Sagar Lonial
Annals of Translational Medicine
|
August 27, 2016
DNA damage, tumor mutational load and their impact on immune responses against cancer
Michalis Liontos, Ioannis Anastasiou, Aristotelis Bamias, et al.
Digestive Diseases and Sciences
|
May 7, 2002
Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome
Spyros Michopoulos, Kalliopi Petraki, Constantina Petraki, et al.
Expert Opinion on Drug Safety
|
June 17, 2021
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation
Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, et al.
Oncotargets and Therapy
|
October 23, 2014
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Michalis Liontos, Maria Lykka, Meletios-Athanasios Dimopoulos, et al.
Page
of 29
Search research articles
Search
Showing results (1-10 of 283) with videos related to
Sort By:
Page
of 29
Biomarker Insights
|
July 7, 2009
Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
Giannis Mountzios, Meletios-Athanasios Dimopoulos, Christos Papadimitriou
Critical Reviews in Oncology/Hematology
|
March 11, 2025
PARP inhibitors during conception and pregnancy in breast cancer
Flora Zagouri, Meletios-Athanasios Dimopoulos, Angeliki Andrikopoulou
Hemasphere
|
September 5, 2020
Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
Despina Fotiou, Meletios Athanasios Dimopoulos, Efstathios Kastritis
Clinical Lymphoma, Myeloma & Leukemia
|
May 30, 2026
Monoclonal Gammopathy of Clinical Significance: A Multisystem Disorder Requiring a Multidisciplinary Approach
Meletios Athanasios Dimopoulos, Foteini Theodorakakou, Efstathios Kastritis
Cancers
|
December 23, 2022
Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma
Despina Fotiou, Meletios Athanasios Dimopoulos, Efstathios Kastritis
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios-Athanasios Dimopoulos, Paul Richardson, Sagar Lonial
Annals of Translational Medicine
|
August 27, 2016
DNA damage, tumor mutational load and their impact on immune responses against cancer
Michalis Liontos, Ioannis Anastasiou, Aristotelis Bamias, et al.
Digestive Diseases and Sciences
|
May 7, 2002
Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome
Spyros Michopoulos, Kalliopi Petraki, Constantina Petraki, et al.
Expert Opinion on Drug Safety
|
June 17, 2021
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation
Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, et al.
Oncotargets and Therapy
|
October 23, 2014
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Michalis Liontos, Maria Lykka, Meletios-Athanasios Dimopoulos, et al.
Page
of 29